ADAR1 Capital Management »

Tyra Biosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Tyra Biosciences (TYRA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Tyra Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Tyra Biosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tyra Biosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $464k 28k 16.40

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Tyra Biosciences

RA Capital Management
Boxer Capital
BVF
Canaan Partners XI
Nextech Invest
FMR
TCG Crossover Management
Fairmount Funds Management
BlackRock
5AM Venture Management
Vanguard Group
Frazier Life Sciences Management
OrbiMed Advisors
Perceptive Advisors
Sio Capital Management

View all funds holding Tyra Biosciences